Company intelligence / Profile preview
Mannin Research Inc.
Toronto, Ontario, Canadamannin.ca ↗
- Ownership
- Private
- Development stage
- Preclinical
01
Overview
Mannin Research Inc. develops novel therapeutics targeting vascular diseases using proprietary platforms focused on the Tie2 receptor and angiopoietin pathways. Lead preclinical data show promise in glaucoma, acute kidney injury, and infectious disease models. The company has received significant grant funding to advance its pipeline.
- Therapeutic areas
- OphthalmologyCardiovascularInfectious DiseasesNephrology
- Modalities
- Small moleculesFusion proteins
- Industry
- Biotech
02
Drug pipeline
4 assets3 more assets in the full pipeline.
Request access →03
Partnerships
Cyclica Inc. – joint venture for rapid development of COVID‑19 drugs using AI-driven drug discovery and Tie2 expertise
Beyond the preview
Go deeper on Mannin Research Inc..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Mannin Research Inc..